Why Canada Is The Future of Uranium Mining
Data centers are expanding at an unprecedented pace, driven by the need to build and train more AI models by the day. But here’s the shocking truth: AI-driven applications like ChatGPT consume
Palantir’s 2024 Stock Surge: Should You Invest Now?
In 2024, Palantir Technologies has seen its stock price more than double, a remarkable run that has captured the attention of investors. Known for its cutting-edge work in artificial intelligence (AI), defense,
Vanguard S&P 500 Growth ETF: Leading the Charge in 2025
In the face of an evolving market landscape, investors are increasingly focusing on funds that offer growth potential, and one ETF that stands out is the Vanguard S&P 500 Growth ETF. This
Nvidia Stock Jumps 4% on $500 Billion AI Investment Plan
What Happened Nvidia (NVDA) shares surged 4% on Wednesday after news broke that the company has been selected as the main technology partner for Stargate’s $500 billion AI infrastructure project. The partnership
Wealth and Power Collide at Trump’s Inauguration
What Happened The inauguration of Donald Trump as the 47th President of the United States on Monday was marked by the presence of the world’s wealthiest individuals, drawing comparisons to the annual
Charles Schwab Reports 44% Profit Surge in Fourth Quarter
What Happened Brokerage firm Charles Schwab announced a 44% rise in profit for the fourth quarter, driven by a significant increase in asset management fees. The news sent Schwab’s shares up by
JPMorgan Chase Posts Record Earnings and Revenue
JPMorgan Chase Posts Record Earnings and Revenue, Setting Banking Milestones JPMorgan Chase reinforced its position as the largest and most profitable U.S. bank by reporting record quarterly and annual earnings and revenue
Eli Lilly Stock Falls 8% on Lower-than-Expected Zepbound Sales Forecast
Eli Lilly Stock Falls 8% on Lower-than-Expected Zepbound Sales Forecast Eli Lilly’s shares dropped 8% on Tuesday after the pharmaceutical giant forecast fourth-quarter sales for its weight-loss drug Zepbound below Wall Street
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion Johnson & Johnson (J&J) announced on Monday its $14.6 billion acquisition of neurological drugmaker Intra-Cellular Therapies, marking its largest deal in over two
Blue Origin Scrubs First New Glenn Rocket Launch Due to Technical Issues
Blue Origin Scrubs First New Glenn Rocket Launch Due to Technical Issues Blue Origin canceled the much-anticipated debut launch of its massive New Glenn rocket early Monday due to technical problems. The
Walgreens Reports Earnings Beat Amid Store Closures and Cost Cuts
Walgreens Reports Earnings Beat Amid Store Closures and Cost Cuts Walgreens reported fiscal first-quarter results on Friday that surpassed Wall Street expectations, as the company undertakes cost-cutting measures, including the closure of
Key Events Ahead: Markets Honor Late President Carter, Fed Insights, and Jobs Report
Markets Closed Thursday for National Day of Mourning Stock markets (^DJI, ^IXIC, ^GSPC) will be closed on Thursday in observance of the national day of mourning for the late President Jimmy Carter.
The Yield on 30-Year US Treasuries Climbs to Highest Level in Over a Year
The yield on 30-year US Treasuries surged to the highest level in more than a year on Monday, offering a preview of how financial markets might react under President-elect Donald Trump’s leadership
